Development of C. burnetii phase II LRVs in mouse PMφ that internalized apoptotic-like or aldehyde-fixed splenocytes. Splenocytes were added at a multiplicity of three cells per macrophage. Twenty-four hours after treatment, cultures were infected with C. burnetii phase II, fixed at different times, and processed as described in Materials and Methods. (A) Percentage of cells with LRVs as a function of the duration of infection. Closed circles, cultures treated with apoptotic-like heated lymphocytes (Apoptosis); open circles, no addition of splenocytes to the cultures (No addition); closed squares, cultures treated with fixed lymphocytes (Fixed). Asterisks indicate statistically significant differences between the treatments (*, P < 0.05; **, P < 0.01). (B) Confocal images of a macrophage culture infected for 6 days with C. burnetii. DIC, Nomarski differential interference contrast; DAPI, DNA fluorescence of the same field; MERGE, superimposed confocal images of DAPI fluorescence (converted to black) and Nomarski DIC (gray). The arrow points to one cell with LRV. N, cell nuclei. Bar = 10 μm.